Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

NCT02792218 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

930

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Ofatumumab subcutaneous injection
DRUG: Teriflunomide-matching placebo capsules
DRUG: Teriflunomide capsule
DRUG: Matching placebo of ofatumumab subcutaneous injections

Sponsor

Novartis Pharmaceuticals